Drug Type Small molecule drug |
Synonyms CS 891, CS 891B, CS-891 + [1] |
Target |
Action inhibitors |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H40N2O3 |
InChIKeyNAGKTIAFDQEFJI-DPMIIFTQSA-N |
CAS Registry142139-60-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Lapisteride | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alopecia | Phase 2 | United States | - | - |
| Alopecia | Phase 2 | Europe | - | - |
| Alopecia | Phase 2 | - | - | |
| Prostatic Hyperplasia | Phase 2 | United States | - | - |
| Prostatic Hyperplasia | Phase 2 | Europe | - | - |
| Prostatic Hyperplasia | Phase 2 | - | - |





